C
RNAM

Covestor’s Avidity Biosciences RNAM Stock Holding History

Covestor’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-256
Closed -$18K – 2697
2025
Q4 		$18K Hold
256
– – 0.01% 1331
2025
Q3 		$11K Hold
256
– – 0.01% 1564
2025
Q2 		$7K Sell
256
-1
-0.4% -$30 ﹤0.01% 1717
2025
Q1 		$8K Buy
257
+3
+1% +$93 0.01% 1640
2024
Q4 		$7K Buy
254
+250
+6,250% +$10.4K ﹤0.01% 1676
2024
Q3 		$0 Sell
4
-2
-33% -$87 ﹤0.01% 2670
2024
Q2 		$0 Sell
6
-3
-33% -$86 ﹤0.01% 2668
2024
Q1 		$0 Sell
9
-1
-10% -$16 ﹤0.01% 2652
2023
Q4 		$0 Sell
10
-1
-9% -$7 ﹤0.01% 2622
2023
Q3 		$0 Buy
11
+5
+83% +$43 ﹤0.01% 2612
2023
Q2 		$0 Hold
6
– – ﹤0.01% 2562
2023
Q1 		$0 Buy
+6
New +$132 ﹤0.01% 2487

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Covestor's RNAM Position: Q1 2026 in Review

Covestor sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 256 shares — an estimated $18K sold.

Covestor first reported a position in RNAM in Q1 2023 and held it in 12 quarters. The position peaked at $18K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Covestor reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Covestor sold 256 Avidity Biosciences shares in Q1 2026, an estimated $18K.
  • Covestor first reported a position in Avidity Biosciences in Q1 2023 and held it in 12 quarters.
  • Covestor's Avidity Biosciences position peaked at $18K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.